- Home
- NDRA vs AKAN Comparison
NDRA vs AKAN Comparison
Compare NDRA & AKAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDRA
- AKAN
- Stock Information
- Founded
- NDRA 2007
- AKAN 2021
- Country
- NDRA United States
- AKAN Canada
- Employees
- NDRA N/A
- AKAN N/A
- Industry
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- AKAN Medicinal Chemicals and Botanical Products
- Sector
- NDRA Health Care
- AKAN Health Care
- Exchange
- NDRA Nasdaq
- AKAN Nasdaq
- Market Cap
- NDRA 3.1M
- AKAN 2.9M
- IPO Year
- NDRA 2017
- AKAN 2022
- Fundamental
- Price
- NDRA $4.74
- AKAN $3.58
- Analyst Decision
- NDRA Strong Buy
- AKAN
- Analyst Count
- NDRA 1
- AKAN 0
- Target Price
- NDRA $46.00
- AKAN N/A
- AVG Volume (30 Days)
- NDRA 27.1K
- AKAN 158.9K
- Earning Date
- NDRA 08-14-2025
- AKAN 10-29-2025
- Dividend Yield
- NDRA N/A
- AKAN N/A
- EPS Growth
- NDRA N/A
- AKAN N/A
- EPS
- NDRA N/A
- AKAN N/A
- Revenue
- NDRA N/A
- AKAN $836,664.00
- Revenue This Year
- NDRA N/A
- AKAN N/A
- Revenue Next Year
- NDRA N/A
- AKAN N/A
- P/E Ratio
- NDRA N/A
- AKAN N/A
- Revenue Growth
- NDRA N/A
- AKAN 97.47
- 52 Week Low
- NDRA $2.90
- AKAN $2.91
- 52 Week High
- NDRA $22.68
- AKAN $8.75
- Technical
- Relative Strength Index (RSI)
- NDRA 54.47
- AKAN 46.62
- Support Level
- NDRA $4.00
- AKAN $3.14
- Resistance Level
- NDRA $4.69
- AKAN $3.86
- Average True Range (ATR)
- NDRA 0.32
- AKAN 0.40
- MACD
- NDRA 0.09
- AKAN -0.04
- Stochastic Oscillator
- NDRA 100.00
- AKAN 35.20
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
About AKAN Akanda Corp.
Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The company has three reportable segments: Cultivation, Distribution, and Corporate. A majority of its revenue is generated from the Distribution segment, which relates to the distribution of medical cannabis products, including cannabis oil and cannabis flower for medical use in the United Kingdom.